Association between apolipoprotein CI HpaI polymorphism and sporadic Alzheimer's disease in Chinese

Acta Neurologica Scandinavica

Volumn 109, Issue 2, 2004, Pages 140-145

  Shi, J ^a,b,c   Zhang, S ^a,b   Ma, C ^c   Liu, X ^a   Li, T ^d   Tang, M ^c   Han, H ^c   Guo, Y ^c   Zhao, J ^e   Zheng, K ^a,b   Kong, X ^a,b   Zhang, K ^a,b   Su, Z ^a,b   Zhao, Z ^c  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Guangzhou Psychiatry Hospital   (China)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e Intl Centre for Health and Society   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein CI; Apolipoprotein E; Genetic polymorphism

Indexed keywords

APOLIPOPROTEIN C1;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHINESE; DEMENTIA; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN C-I; APOLIPOPROTEINS C; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX;

EID: 0842286659     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00193.x     Document Type: Article

References (33)

1. BLACKER D, HAINES JL, RODES L et al. APOE-4 and age-at -onset of Alzheimer disease: the NIMH Genetics Initiative. Neurology 1997;48:139-47.
2. BLACKER D, TANZI RE. The genetics of Alzheimer's disease: current status and future prospects. Arch Neurol 1998;55:294-6.
3. FARRER LA, CUPPLES LA, HAINES JL et al. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and Alzhiemer's disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-56.
4. POIRIER J, DAVIGNON J, BOUTHILLIER D, KOGAN S, BERTRAND P, GAUTHIER S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
5. TSAI MS, TANGALOS EG, PETERSEN RC et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994;54:643-9.
6. SMIT M, VAN DER KOOIJ-MEIJS E, FRANTS R, HAVEKES L, KLASEN E. Apolipoprotein gene cluster on chromosome 19: definite localization of the APOC2 gene and the polymorphic HpaI site associated with type III hyperlipoproteinemia. Hum Genet 1988;78:90-3.
7. LAUER SJ, WALKER D, ELSHOURBAGY NA, REARDON C, LEVY-WILSON B, TAYLOR JM. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J Biol Chem 1988;263:7277-86.
8. DRIGALENKO E, PODUSLO S, ELSTON R. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology 1998;51:131-5.
9. PODUSLO SE, NEAL M, SCHWANKHAUS J. A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease. Neurosci Lett 1995;201:81-3.
10. PODUSLO SE, NEAL M, HERRING K, SHELLY J. The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem Res 1998;23:361-7.
11. RETZ W, THOME J, DURANCY N et al. Potential genetic markers of sporadic Alzheimer's dementia. Psychiat Genet 2001;11:115-22.
12. KI CS, NA DL, KIM DK, KIM HJ, KIM JW. Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease. Neurosci Lett 2002;319:75-8.
13. KAMINO K, YOSHIIWA A, NISHIWAKI Y et al. Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster. Gerontology 1996;42(Suppl. 1):12-9.
14. CHARTIER-HARLIN MC, PARFITT M, LEGRAIN S et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994;3:569-74.
15. TYSOE C, GALINSKY D, ROBINSON D et al. Apo E and Apo CI loci are associated with dementia in younger but not older late-onset cases. Dement Geriatr Cogn Disord 1998;9: 191-8.
16. MCKHANN GM, DRACHMAN D, FOLSTEIN M, KATZMAN R, PRICE D, STADLAN EM. Clinical diagnosis of Alzheimer's disease: report of the NINCD-ADRDA work group under the auspices of the Department of Health and Human Services Task Forces on Alzheimer's disease. Neurology 1984; 34:939-44.
17. HUGHES CP, BERG L, DANZIGER WL, COBEN LA, MARTIN RL. A new clinical scale for the staging of dementia. Brit J Psychiat 1982;140:566-72.
18. FOLSTEIN MF, ROBINS LN, HELZER JE. The Mini-Mental State Examination. Arch Gen Psychiatry 1983;40:812.
19. NILLESEN WM, SMEETS HJM, VAN OOST BA. Human ApoCI Hpa I restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res 1990;18: 3428.
20. HIXSON JE, VERNIER DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-8.
21. ZAPATA C, CAROLLO C, RODRIGUEZ S. Sampling variance and distribution of the D' measure of overall gametic disequlibrium between multiallelic loci. Ann Hum Genet 2001; 65:395-406.
22. HONG CJ, LIU TY, LIU H-C et al. ε4 allele of the apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 1996;46:1749-51.
23. LEE DW, LIU HC, LIU TY, CHI CW, HONG CJ. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese. Am J Med Genet 2000;96:167-9.
24. MAK YT, CHIU H, Woo J et al. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-9.
25. BARTRES-FAZ D, CLEMENTE IC, JUNQUE C et al. APOE and APOC1 genetic polymorphisms in age-associated memory impairment. Neurogenetics 2001;3:215-9.
26. WEISGRABER KH, MAHLEY RW, KOWAL RC, HERZ J, GOLDSTEIN JL, BROWN MS. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem 1990;265:22453-9.
27. SEHAYEK E, EISENBERG S. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem 1991;266:18259-67.
28. SHACHTER NS, EBARA T, RAMAKRISHNAN R et al. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 1996;98:846-55.
29. JONG MC, HOFKER MH, HAVEKES LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999;19:472-84.
30. KNOTT TJ, ROBERTSON ME, PRIESTLEY LM, URDEA M, WALLIS S, SCOTT J. Characterisation of mRNAs encoding the precursor for human apolipoprotein CI. Nucleic Acids Res 1984;12:3909-15.
31. GAUTIER T, MASSON D, DE BARROS JP et al. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity. J Biol Chem 2000;275:37504-9.
32. XU Y, BERGLUND L, RAMAKRISHNAN R et al. A common HpaI RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lip Res 1999;40:50-8.
33. PETIT-TURCOTTE C, STOHL SM, BEERT U et al. Apolipoprotein C-I expression in the brain in Alzheimer's disease. Neurobiol Dis 2001;8:953-63.